Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.002106712691889125	55.34101382488479	-100.98537671170521	IL6;NFKB1;TLR4
KEGG_2021_Human	Legionellosis	3/57	3.859950954844004e-05	0.002106712691889125	63.6031746031746	-112.5302356283168	IL6;NFKB1;TLR4
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.002106712691889125	24.824644549763033	-68.34725873383007	AGER;IL6;NFKB1;TLR4
KEGG_2021_Human	Pertussis	3/76	9.159620399517935e-05	0.002106712691889125	46.93737769080235	-88.55605413655218	IL6;NFKB1;TLR4
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0026791250046749337	35.2179675994109	-69.8003308229761	AGER;IL6;NFKB1
KEGG_2021_Human	Toll-like receptor signaling pathway	3/104	0.0002329673917108638	0.0026791250046749337	33.806223479490804	-67.40758155759835	IL6;NFKB1;TLR4
KEGG_2021_Human	Chagas disease	3/102	0.00021994493140062025	0.0026791250046749337	34.497835497835496	-68.58379435140506	IL6;NFKB1;TLR4
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0026791250046749337	34.497835497835496	-68.58379435140506	IL6;NFKB1;TLR4
KEGG_2021_Human	HIF-1 signaling pathway	3/109	0.00026769368967035696	0.002736424383296982	32.19137466307278	-64.6303441766756	IL6;NFKB1;TLR4
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.004580192973133257	25.375266524520256	-52.38188378130509	IL6;NFKB1;TLR4
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.004580192973133257	24.99579831932773	-51.672386684351224	IL6;NFKB1;TLR4
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.005773905036597514	22.31954887218045	-46.57552582678881	ADIPOQ;IL6;NFKB1
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.0060622035287802	21.318059299191376	-44.62403509135876	IL6;NFKB1;TLR4
KEGG_2021_Human	Influenza A	3/172	0.001019644326496313	0.0067005198598329135	20.0312764158918	-42.078889135072146	IL6;NFKB1;TLR4
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.006797996380561927	19.106537530266344	-40.222430877266724	IL6;NFKB1;TLR4
KEGG_2021_Human	NOD-like receptor signaling pathway	3/181	0.0011822602400977265	0.006797996380561927	18.996789727126806	-40.00053498134924	IL6;NFKB1;TLR4
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.007251485478266222	18.161290322580644	-38.30003183551744	AGER;NFKB1;TLR4
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.007719975278369176	17.394698085419734	-36.72187076283526	IL6;NFKB1;TLR4
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.007926556047276524	41.770833333333336	-50.1560330081587	IL6;TLR4
KEGG_2021_Human	Coronavirus disease	3/232	0.0024164136009215383	0.011115502564239077	14.670617592014972	-30.966105875434415	IL6;NFKB1;TLR4
KEGG_2021_Human	Cytosolic DNA-sensing pathway	2/63	0.00258752682682323	0.011335831812749388	32.8155737704918	-41.182346051003734	IL6;NFKB1
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.012364957665854414	13.627177700348431	-28.69609856443984	IL6;NFKB1;TLR4
KEGG_2021_Human	Adipocytokine signaling pathway	2/69	0.0030959091544989293	0.012383636617995717	29.854477611940297	-38.032897794694755	ADIPOQ;NFKB1
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.014723613855730993	26.643333333333334	-34.49723066158141	NFKB1;TLR4
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.018767598537865898	22.933908045977013	-30.23706529396038	NFKB1;TLR4
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.01933247392268519	21.914835164835164	-29.03004575134454	IL6;TLR4
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.01933247392268519	21.67391304347826	-28.742216935482162	IL6;NFKB1
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.020957747872156242	19.524509803921568	-26.130280011490946	IL6;NFKB1
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.020957747872156242	18.086363636363636	-24.33571316400054	NFKB1;TLR4
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.020957747872156242	18.778301886792452	-25.204052222837845	IL6;NFKB1
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.020957747872156242	19.92	-26.61700675496218	ADIPOQ;NFKB1
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.020957747872156242	18.086363636363636	-24.33571316400054	IL6;NFKB1
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.020957747872156242	9.422466422466423	-19.140881053489387	IL6;NFKB1;TLR4
KEGG_2021_Human	NF-kappa B signaling pathway	2/104	0.006906399428166279	0.020957747872156242	19.524509803921568	-26.130280011490946	NFKB1;TLR4
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.020957747872156242	18.95952380952381	-25.42995427691617	IL6;NFKB1
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.022805917939003804	9.018735362997658	-18.187178129854335	AGER;IL6;NFKB1
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.03745319840326484	12.847402597402597	-17.429441058365175	IL6;NFKB1
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.043027350053792005	6.897094430992736	-13.07371705691191	AGER;IL6;NFKB1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.051808810895917684	10.31020942408377	-13.840129933766221	IL6;NFKB1
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.051808810895917684	10.365789473684211	-13.920708621090329	IL6;NFKB1
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.0542413021184777	9.784825870646767	-13.073912909097736	AGER;NFKB1
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.0542413021184777	9.835	-13.147442958027579	IL6;NFKB1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	2/212	0.026851997557997137	0.05745078547292411	9.354761904761904	-12.440530405951861	NFKB1;TLR4
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.05964619465488999	9.044930875576037	-11.980722307867735	IL6;NFKB1
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.06132376638660801	8.794843049327355	-11.607417281005194	IL6;NFKB1
KEGG_2021_Human	Shigellosis	2/246	0.035374463538784595	0.07074892707756919	8.01639344262295	-10.432967830507518	NFKB1;TLR4
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.0878801205017715	24.790123456790123	-13.876145105511855	IL6
KEGG_2021_Human	Graft-versus-host disease	1/42	0.05082096328161841	0.09740684628976863	21.75338753387534	-12.4264883862275	IL6
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.0538910819803677	0.10118325596313935	6.298701298701299	-7.775300015246377	MIR483;NFKB1
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.10218930320985573	19.809876543209878	-11.46289716991079	ADIPOQ
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.10442558472144292	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.10449313311324025	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.1370103367273977	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.1370103367273977	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.1370103367273977	13.47138047138047	-8.082458738692866	NFKB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.1370103367273977	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.14072253566782097	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.09024597396088518	0.14072253566782097	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	PPAR signaling pathway	1/74	0.0879683156429337	0.14072253566782097	12.168949771689498	-7.333238410134627	ADIPOQ
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.09591773965141367	0.14707386746550097	11.094444444444445	-6.698191160265787	NFKB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.1581286618039617	9.739926739926739	-5.8737398650795125	NFKB1
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.1581286618039617	9.739926739926739	-5.8737398650795125	NFKB1
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.1581286618039617	9.961298377028713	-6.010407578745034	IL6
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.15886631545744906	9.528076463560334	-5.7422174156532195	HAMP
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.16090578093852892	8.94388327721661	-5.375723879218761	IL6
KEGG_2021_Human	Hematopoietic cell lineage	1/99	0.11607356788707196	0.16090578093852892	9.036281179138323	-5.434068642481248	IL6
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.16090578093852892	9.226851851851851	-5.553951626329874	NFKB1
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.1639461977244345	3.816532258064516	-3.814605004177811	IL6;NFKB1
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.1639461977244345	8.592233009708737	-5.152341092635986	NFKB1
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.175275025231167	7.4220354808590105	-4.393179099544486	ADIPOQ
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.175275025231167	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.175275025231167	3.5628544423440456	-3.410136075895621	IL6;NFKB1
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.175275025231167	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.18228942547251945	7.00352733686067	-4.115510268264927	NFKB1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.18249055678400464	6.892361111111111	-4.041189892105298	NFKB1
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.18268051768811555	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.19048026955439987	6.384863123993559	-3.698840756963446	NFKB1
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.1917804691957095	6.2466509062253746	-3.6047270952512624	NFKB1
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.20157867533055465	5.82560706401766	-3.3156870475343334	TLR4
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.2048679473775606	5.562587904360056	-3.1333425612983894	TLR4
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.2048679473775606	5.635327635327635	-3.183908163692195	NFKB1
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.20584930308676977	5.456866804692892	-3.0596637281364782	IL6
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.23710903738430147	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.24546004283759099	4.283224400871459	-2.2275706216550177	TLR4
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.24546004283759099	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.25409693075873485	4.058397932816537	-2.065502377074288	NFKB1
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.2674449992416981	3.7696007696007694	-1.8563524399324505	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.27135022567830186	3.6554621848739495	-1.7734497985532327	NFKB1
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.3008770601565506	3.184640522875817	-1.4307154955453085	IL6
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3142237685135	2.9380196523053668	-1.2513063817932166	IL6
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.3142237685135	2.9484262419416005	-1.2588658824557653	NFKB1
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.3420488957114324	2.6053872053872054	-1.0106876845884132	NFKB1
